Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (NASDAQ:CYCCP) declared a quarterly dividend on Thursday, March 14th, Wall Street Journal reports. Investors of record on Monday, April 15th will be given a dividend of 0.15 per share on Wednesday, May 1st. This represents a $0.60 dividend on an annualized basis and a yield of 11.11%. The ex-dividend date of this dividend is Friday, April 12th.

NASDAQ:CYCCP traded up $0.12 during mid-day trading on Thursday, reaching $5.40. 1,850 shares of the stock were exchanged, compared to its average volume of 1,367. Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs has a 1 year low of $4.85 and a 1 year high of $7.00.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/cyclacel-pharmaceuticals-inc-6-conv-pref-shrs-to-issue-quarterly-dividend-of-0-15-cyccp/2890498.html.

Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs Company Profile

Cyclacel Pharmaceuticals, Inc, a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapacitabine, a novel orally-available nucleoside analog that is in Phase III clinical trial for the front-line treatment of acute myeloid leukemia; and Phase II clinical trial for the treatment of myelodysplastic syndromes.

Recommended Story: Percentage Decliners

Dividend History for Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (NASDAQ:CYCCP)

Receive News & Ratings for Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs and related companies with MarketBeat.com's FREE daily email newsletter.